FDA Approves First Gene Therapy for Children with MLD
The U.S. Food and Drug Administration has recently approved Lenmeldy (atidarsagene autotemcel), the first FDA-approved gene therapy
Metachromatic Leukodystrophy | 20/03/2024 | By Manvi | 249
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy